Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05532423 · ClinicalTrials.gov registry record · Early Phase 1
Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome
A Early Phase 1 study, sponsored by Penn State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 22
- Enrollment target
NCT05532423 is a Early Phase 1 study that has completed, run by Penn State University. The registered enrollment target is 22 participants.
The verdict
NCT05532423, a Early Phase 1 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if beetroot juice consumption can improve cognitive performance and brain vascular function in individuals with metabolic syndrome
Interventions
- DRUG Beetroot Juice - Active
- DRUG beetroot juice - Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-12-01 |
| Est. Completion | 2024-08-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05532423
The ClinicalTrials.gov registry entry for NCT05532423 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Beetroot Juice - Active is the first listed.
NCT05532423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05532423 about?
NCT05532423 is a clinical study titled "Nitrate Supplementation and Cerebrovascular and Cognitive Function in Metabolic Syndrome". The purpose of this study is to determine if beetroot juice consumption can improve cognitive performance and brain vascular function in individuals with metabolic syndrome
What is the current status of trial NCT05532423?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 22 participants. The study started on 2022-12-01. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT05532423?
The interventions under investigation include: Beetroot Juice - Active (DRUG), beetroot juice - Placebo (DRUG).
Who is sponsoring clinical trial NCT05532423?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.